Table 1.

Clinical and pathological characteristics of patients with initial diagnosis of AJCC stage II–IV melanoma

Age (year)
Median	49
Range	17–79
Gender	No. of patients (%)
Male	295 (63)
Female	171 (37)
Primary site
Head and neck	68 (15)
Extremities	193 (41)
Trunk	167 (36)
Other	38 (8)
Stage
II	115 (25)
III	328 (70)
IV	23 (5)
Adjuvant therapy
00C0216 (Tyr 240-251/IF or gp100	204 (44)
03C0172 (MART 1:27-35)	113 (24)
06C0069 (gp100:209-217M/montar)	101 (22)
08C0162 (MART F5TCR +ALVAC)	48 (10)
Total	466

Total enrolled: 491

Total evaluable: 466

Not evaluable: 25